Freenome's first public quarter brings a 180 million FDA-driven revenue jump.
Why Is FRNM (FRNM) Stock Down Today?
Updated Nov 22, 2026 6:57 AM ET ยท Prev Close $9.93
Session Regime & Catalyst Assessment
68% Signal ConvictionFRNM Pulling Back 5.69% on 0.75x Relative Volume
Frnm (Frnm) is pulling back 5.69% (-$0.57) to $9.36 on 0.75x average session volume. Relative to benchmarks, FRNM is lagging the S&P 500 by -2.05%. 14-day RSI stands at 31.3, keeping momentum in a bearish regime.
Freenome's first public quarter brings a 180 million FDA-driven revenue jump.
Price ($9.36) trades relative to 20-day SMA ($11.12) and 50-day SMA ($13.40).
Market & Sector Relative Strength
FRNM lagging the S&P 500 by -2.05%Options Flow & Execution Desk
Recent FRNM Catalyst Headlines
Verified WireBrisbane, Calif., Nov. 17, 2026 Globe Newswire -- Freenome, Inc. Nasdaq Frnm , a personalized cancer detection company using an AI-driven multiomics platform to develop and optimize single- and multi-cancer blood tests,
Inflation worries are back on the front page, with US wholesale prices rising 6.5 year on year in October and feeding fresh debate about how long higher rates could stick around. Expensive capital and rising costs can be
Freenome Nasdaq Frnm reported third-quarter revenue of 183.5 million, driven largely by revenue recognition following the U.S. Food and Drug Administration s approval of its blood-based colorectal cancer screening test.
1โ3 Day Expected Range & Key Level
48% Follow-ThroughMonitor volume expansion above 1.5x RVOL around $9.28 (session support) for directional breakout confirmation.
Technical Regime (FRNM)
BEARISH MA TRENDAbout FRNM
Get Instant FRNM Catalyst Alerts
Receive an email alert when FRNM triggers an unusual volume breakout, options sweep, or rating shift.
FRNM Session & Catalyst FAQ
Why is FRNM stock down today?
Frnm (Frnm) is pulling back 5.69% (-$0.57) to $9.36 on 0.75x average session volume. Relative to benchmarks, FRNM is lagging the S&P 500 by -2.05%. 14-day RSI stands at 31.3, keeping momentum in a bearish regime.
Is FRNM stock a buy or sell right now?
Today's session carries a 68% catalyst conviction score on 0.75x relative volume (low participation). Our multi-factor model currently rates FRNM as HOLD. Review full valuation, quality, and timing signals on the FRNM Buy or Sell Decision Brief โ
What is FRNM's intrinsic value and expected trading range?
At $9.36, FRNM's modeled 1-to-3 session range is $8.85 โ $9.87, with a key inflection level at $9.28 (session support). Compare current price against multi-year cash flow projections in the FRNM Intrinsic Value & DCF Model โ and Market Cycle Phase Tracker โ
What do RSI and moving averages signal for FRNM?
RSI at 31.3 reflects soft below-midline momentum. FRNM trades at $9.36 relative to its 20-day SMA ($11.12) and 50-day SMA ($13.40), reflecting a bearish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.